期刊文献+

半胱氨酸蛋白酶抑制剂C对自发性高血压大鼠心肌纤维化的影响 被引量:2

Effect of cystatin C on myocardial fibrosis in spontaneously hypertensive rats
原文传递
导出
摘要 目的探讨半胱氨酸蛋白酶抑制剂C(cystatin C)对于自发性高血压大鼠(SHR)心肌纤维化的影响。方法培养16周龄的自发性高血压大鼠心肌成纤维细胞(CFs),将构建成功含cystatin C的腺病毒载体转染SHR的CFs及心室肌中,随机分为空白对照组、Ad-GFP组和Ad-CysC组。通过w estern blot检测cystatin C在CFs和SHR心室肌中的表达情况。用实时定量PCR测定CFs的Ⅰ、Ⅲ胶原mRNA水平。行超声心动检查评定转染后4周SHR的心脏结构和心功能。通过Masson染色分析SHR的心肌纤维化程度。结果 Cystatin C在Ad-CysC组CFs和心室肌中表达较空白对照组和Ad-GFP组明显增强(P均<0.05);与空白对照组和Ad-GFP组相比,Ad-CysC组CFs中Ⅰ、Ⅲ胶原mRNA表达显著增加(P均<0.05);Ad-CysC组LVMI、IVSD、LVPWD、CVF和PVCA明显高于空白对照组和Ad-GFP组,LVEDD较其余两组明显减小(P均<0.05)。上述指标在空白对照组和Ad-GFP组中差异均无统计学意义(P>0.05)。结论 Cystatin C使SHR成纤维细胞胶原合成增多,具有促进心肌纤维化进程的作用。 Objective To investigate the effect of cystatin C on myocardial fibrosis in spontaneously hypertensive rats(SHR).Methods Cardiac fibroblasts(CFs) of SHR aged 16 weeks were cultured in vitro.The recombinant adenovirus vector for cystatin C was transfected into CFs and the ventricular myocardium.All rats were randomly divided into 3 groups: the normal control group,the Ad-GFP group and the Ad-CysC group.Expression of cystatin C in CFs and the ventricular myocardium was determined by means of Western blot.MRNA expressions of collagen Ⅰ and Ⅲ were determined by RT-PCR.Echocardiography was used to evaluate the cardiac structure and function after transfection for 4 weeks.Myocardial fibrosis was analyzed with Masson′s staining.Results Protein expression of cystatin C was increased in CFs and the ventricle myocardium in the Ad-CysC group when compared with the normal control group and the Ad-GFP group(both P0.05).Compared with the normal control group and the Ad-GFP group,mRNA expressions of collagenⅠ and Ⅲ were increased in the Ad-CysC group(both P0.05);The LVMI,IVSD,LVPWD,CVF and PVCA were more increased and the LVEDD was more decreased in the Ad-CysC group than the normal control group and the Ad-GFP group(all P0.05),while there was no statistical significance between the Ad-GFP group and the normal control group(P0.05).Conclusion Cystatin C promotes collagen synthesis in CFs and may play a role in the progression of myocardial fibrosis in SHR.
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第12期42-47,共6页 Journal of Shandong University:Health Sciences
基金 山东省科学技术发展计划资助项目(2007GG20002028)
关键词 半胱氨酸蛋白酶抑制剂C 自发性高血压大鼠 心肌成纤维细胞 Ⅲ胶原蛋白 Cystatin C Spontaneously hypertensive rats Cardiac fibroblasts CollagenⅠand Ⅲ
  • 相关文献

参考文献17

  • 1Guido Krenning,Elisabeth M,Zeisberg,et al.The originof fibroblasts and mechanism of cardiac fibrosis[J].JCell Physiol,2010,225(3):631-637.
  • 2Weber K T,Clark W A,Janicki J S,et al.Physiologicversus pathologic hypertrophy and the pressure-overloadedmyocardium[J].J Cardiovasc Pharmacol,1987,10(6):37-50.
  • 3Berk B C.Vascular smooth muscle growth:autocrinegrow th mechanisms[J].Physiol Rev,2001,81(3):999-1030.
  • 4Frohlich E D.Left ventricular hypertrophy:dissociationof structural and functional effects by therapy[J].AdvExp Med Biol,1991,308:175-190.
  • 5Berk B C,Fujiwara K,Lehoux S.ECM remodeling inhypertensive heart disease[J].J Clin Invest,2007,117(3):568-575.
  • 6Shlipak M G,Sarnak M J,Katz R,et al.Cystatin C andthe risk of death and cardiovascular events among elderlypersons[J].N Engl J Med,2005,352(20):2049-2060.
  • 7Sun Q.Growth stimulation of3T3fibroblasts by cystatin[J].Exp Cell Res,1989,180(1):150-160.
  • 8Opsah I J A,Abraham P A,Halstenson C E,et al.Cor-relation of office and ambulatory blood pressure measure-ments w ith urinary albumin and N-acetyl-β-D-glucosamin-idase excretions in essential hypertension[J].Am J Hy-pertens,1988,1(3):117-120.
  • 9Barka T,van der Noen H.Expression of the cysteine pro-teinase inhibitor Cystatin C gene in rat heart:use of digoxigenin-labeled probes generated by polymerase chain reac-tion directly for in situ and northern blot hy bridizations[J].J Histochem Cytochem,1993,41(12):1863-1867.
  • 10Xie L,Terrand J,Xu B,et al.Cystatin C increases incardiac injury:a role in extracellular matrix protein mod-ulation[J].Cardiovasc Res,2010,87(4):628-635.

二级参考文献11

  • 1Eva Kolwijck,Leon F. A. G. Massuger,Chris M. G. Thomas,Paul N. Span,Marta Krasovec,Janko Kos,Fred C. G. J. Sweep.Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors[J]. Journal of Cancer Research and Clinical Oncology . 2010 (5)
  • 2Yang L,Zou X J,Gao X,et al.Sodium tanshinone IIAsulfonate attenuates angiotensin II-induced collagen type Iexpression in cardiac fibroblasts in vitro. Experimental and Molecular Medicine . 2009
  • 3Xie L,Terrand J,Xu B,et al.Cystatin C increases incardiac injury:A role in extracellular matrix protein mod-ulation. Cardiovascular Research . 2010
  • 4Sun Q.Growth stimulation of 3T3 fibroblasts by cystatin. Experimental Cell Research . 1989
  • 5Hill JA,Olson EN.Cardiac plasticity. The New England Journal of Medicine . 2008
  • 6Lindholt J S,Erlandsen E J,Henneberg E W.Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. The British Journal of Surgery . 2001
  • 7Taupin P,Ray J,Fischer WH,et al.FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron . 2000
  • 8Korolenko TA,Filatova TG,Cherkanova MS,et al.Cystatins:cy-steine proteases regulation and disturbances in tumors and infla-mmation. Bioorganicheskaia khimiia . 2008
  • 9Moran A,Katz R,Jenny NS,Astor B, et al.Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C:the multi-ethnic study of atherosclerosis (MESA). American Journal of Kidney Diseases . 2008
  • 10Sokol JP,Schiemann WP.Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Molecular Cancer Research . 2004

共引文献4

同被引文献35

  • 1张春晓,木胡牙提.心衰患者血浆Hcy、Cys-C水平变化及相关性研究[J].世界最新医学信息文摘,2019,0(89):29-30. 被引量:3
  • 2中国高血压防治指南修订版.中国高血压防治指南[J].高血压杂志,2010,19(8):701-43.
  • 3Kathodi R E,Couri D M. Left ventricular hypertrophy:major risk factor in patients with hypertension:update and practical elincical applications [ J ]. Int J Hypertens ,2011,2011:495349.
  • 4Bell D, Zhao Y, McCoy F P, et al. Expression of the counter-regula- tory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes [ J ]. Cell Physiol Biochem, 2008,21 ( 5 - 6) :409 - 20.
  • 5Liang Y, Xue L H, Li J R, et al. Effect and mechanism of interme- din 1-53 on two-kidney one-clip hypertensive rats [ J ]. Chin Phar- macol Bull ,2011,27 ( 1 ) :46 - 9.
  • 6Song J Q ,Teng X, Cai Y, et al. Activation of AkVGSK-3beta signa- ling pathway is involved in intermedin (1-53) protection against myocardial apoptosis induced by ischemia/reperfusion [ J]. Apopto- sis,2009,14(11 ) :1299 -307.
  • 7Imai A, Komatsu S, Ohara T, et al. Serum cystatin C is associated with early stage coronary atheroselerotic plaque morphology on mul- tidetector computed tomography [ J ]. Atherosclerosis, 2011,218 (2) :350 -5.
  • 8Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension [ J ]. Hypertens Res,2003,26 ( 11 ) : 895 - 9.
  • 9Patel P C, Ayers C R, Murphy S A, etal. Association of cystatin C with left ventricular structure and function:The Dallas Heart Study [ J]. Circ Heart Fail,2009,2(2) :98 -104.
  • 10Mirza M A, Larsson A, Lind L, et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community [ J ]. Atherosclerosis,2009,205 (2) : 385 - 90.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部